Price controls and compulsory licences lead to double trouble in India

Last week, an Indian panel of ministers proposed that that the government put all 348 drugs on the country’s National List of Essential Medicines under price control, including a number of patented drugs. The structure of the scheme provides incentives to target patented drugs on the list